Evidence map›Paper›PMID 10857967›Full record

ArticleDiabetes care2000

Fasting plasma glucose variability predicts 10-year survival of type 2 diabetic patients: the Verona Diabetes Study.

M Muggeo, G Zoppini, E Bonora, E Brun, R C Bonadonna, P Moghetti, G Verlato

2 registry-linked trialsAbstract read
PubMed Publisher
In one paragraph

Article in Diabetes care, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 100 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
100citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02587741 early_phase1unknown statusstarted 2015, after this paper: background citation

Comparison of Diabetes Retinopathy Among Type 2 Diabetic Patients Treated With Different Regimens: a Multicentre Randomized Parallel-group Clinical Trial

Ran2015Enrolled600Registered outcomes6Posted comparisons0ConditionsDiabetic RetinopathyArmsLantus, Metformin, Novomix30
Open the trial in the graph
NCT02526810 phase4unknown statusnot on this mapstarted 2015, after this paper: background citation

Comparison of Glycaemic Fluctuation and Oxidative Stress Between Two Short-term Therapies for Type 2 Diabetes

TypeinterventionalSponsorThird Affiliated Hospital, Sun Yat-Sen UniversityRan2015 to 2016Enrolled70ConditionsDiabetes Mellitus, Type 2Armsinsulin lispro, Insulin Glargine
3 · Its place in the literature

Who cites it

100 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Trial
  4. CPAP therapy of obstructive sleep apnea in type 2 diabetics improves glycemic control during sleep.Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine · 2008
    Trial
  5. Article
  6. Observational
  7. Observational
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Endothelial Dysfunction and Platelet Hyperactivation in Diabetic Complications Induced by Glycemic Variability.Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme · 2022
    Review
  17. Article
  18. Article
  19. Article
  20. Article

40 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

M MuggeoDivision of Endocrinology and Metabolic Diseases, University of Verona Medical School, Italy. malmetab@borgotrento.univr.it
G Zoppini
E Bonora
E Brun
R C Bonadonna
P Moghetti
G Verlato

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveIn the present study, we evaluated whether the coefficient of variation (CV) of fasting plasma glucose (FPG) over a 3-year period was a significant predictor of mortality in type 2 diabetic patients aged 56-74 years. RESEARCH DESIGN AND

methodsAll type 2 diabetic patients (n = 1,409) aged 56-74 years attending the Verona Diabetes Clinic and having at least two FPG determinations in each of the years 1984-1986 were followed for 10 years (1987-1996) to assess total and cause-specific mortality Patients were grouped into tertiles of mean and CV of FPG during 1984-1986. These parameters as well as sex, age, diabetes duration, insulin treatment, smoking, hypertension, and hypercholesterolemia were included in multivariate survival analyses.

resultsDuring the follow-up, 468 patients died. The CV of FPG was an independent predictor of total, cardiovascular, and cancer mortality. Mean FPG was a predictor of total mortality only when the CV of FPG was not included in the analyses.

conclusionsLong-term variability of fasting glucose is an independent predictor of mortality in patients with type 2 diabetes. The CV of FPG might be considered a useful additional parameter in the management of these patients.

Indexed as

FastingAgedAnalysis of VarianceBlood GlucoseDiabetes Mellitus, Type 2Diabetic AngiopathiesFemaleHumansHypercholesterolemiaHypertensionItalyMaleMiddle AgedPrevalenceProbabilitySmokingBlood Glucose

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.